Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
126.3 USD | +0.37% |
|
+1.98% | +15.80% |
07-03 | Stocks to watch as Biden and Trump vie for presidency | RE |
07-01 | Merck, Orion Convert Ongoing Collaboration Into Exclusive Global License for Opevesostat | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.80% | 319B | |
+55.90% | 809B | |
+39.52% | 624B | |
-7.33% | 351B | |
+6.42% | 289B | |
+13.34% | 240B | |
+13.97% | 220B | |
-0.25% | 219B | |
+8.04% | 166B | |
-2.83% | 157B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Transcript : Merck & Co., Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 03